
Safety

infection, deaths, hemorrhage
INFECTION, CARDIORESPIRATORY FAILURE, HEMORRHAGE, HEART FAILURE
At the time of data cutoff, 15 unrelated deaths occurred: 11 (9.9%) in the eltrombopag arm for infection in five, cardiorespiratory failure in two, hemorrhage in one, and worsening of general condition in three; and four (7.4%) in the placebo arm for infection, heart failure, hemorrhage, and worsening of general condition. Median survival was not reached for both arms with no difference in overall cumulative survival between arms (log-rank test; 